The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
5-FU induced encephalopathy during 5-FU containing regimen for esophageal squamous cell carcinoma.
Ken Kato
No relevant relationships to disclose
Kohei Akiyoshi
No relevant relationships to disclose
Nobukazu Hokamura
No relevant relationships to disclose
Hiroyasu Igaki
No relevant relationships to disclose
Yuji Tachimori
No relevant relationships to disclose
Yoshitaka Honma
No relevant relationships to disclose
Satoru Iwasa
No relevant relationships to disclose
Tetsuya Hamaguchi
No relevant relationships to disclose
Yasuhide Yamada
No relevant relationships to disclose
Yasuhiro Shimada
No relevant relationships to disclose